NeoAg Summit 2019

4th Annual NeoAg Summit is organized by Hanson Wade and will be held from Nov 20 - 22, 2019 at The Colonnade Hotel, Boston, Massachusetts, United States of America.

Description:
The NeoAg Summit is the only industry-dedicated meeting focused on the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies.

Neoantigen-targeted therapies are fast becoming the hottest area in personalized immunotherapies. With significant breakthroughs in technology, join us as we optimize the discovery and prediction of neoantigens, accelerating the industry to advance into clinic and effectively target tumor indications.

The NeoAg Summit brings together the pioneers weaponizing neoantigen immunotherapy and vaccine development to share key clinical data and insights from sample acquisition, all the way through to vaccine manufacturing and market approval.

At the NeoAg Summit, we bring together the leading pharma and biotech companies to discuss:
• Advance neoantigen prediction approaches
• Improve immunogenicity and learn combination strategies
• Scale manufacture to improve the commercial potential of personalized therapies

Join the leaders from Genocea, Gritstone, Neon Therapeutics, Ziopharm Oncology, Parker Institute for Cancer Immunotherapy, La Jolla Institute for Allergy and Immunology and many more to spur on more efficacious personalised cancer vaccines and cell therapies.

Additional details will be posted as soon as they are available.